Texas Health Harris Methodist Hospital
Welcome,         Profile    Billing    Logout  
 4 Trials 
14 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kunavarapu, Chandra
APEX-AV, NCT05318092: Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism

Completed
N/A
122
US
AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE
Angiodynamics, Inc.
Pulmonary Embolism, Acute Pulmonary Embolism
01/24
01/24
PEERLESS, NCT05111613: The Study

Completed
N/A
692
Europe, US
Catheter-Directed Thrombolysis, FlowTriever System
Inari Medical
Pulmonary Embolism, Pulmonary Thrombo-embolism
03/24
04/24
NCT06055920: The PEERLESS II Study

Recruiting
N/A
1200
Europe, Canada, US
FlowTriever System, Anticoagulation Agents
Inari Medical
Pulmonary Embolism
07/26
07/26
NCT05934487: PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Recruiting
N/A
1650
US
Cordella™ Pulmonary Artery Sensor System
Endotronix, Inc.
Heart Failure NYHA Class II, Heart Failure NYHA Class III
09/27
09/29
II, John H Fischer
BLADE-VG2, NCT05539963: A Feasibility Trial to Investigate the Safety and Between-group Effect Size of STIMULAN VG and Standard of Care (SoC) in Participants With Diabetic Foot Osteomyelitis

Recruiting
2
60
US
STIMULAN VG, Systemic Antibiotics
Biocomposites Ltd, MCRA
Diabetic Foot Osteomyelitis
12/24
12/25
CLN-418-001, NCT05306444: CLN-418 Study on Subjects With Advanced Solid Tumors

Completed
1
48
US, RoW
CLN-418, HBM7008
Cullinan Therapeutics Inc., Harbour BioMed US, Inc.
Advanced Solid Tumor
08/24
09/24
NCT05878691: A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas.

Active, not recruiting
1
320
US, RoW
GRC 54276, GRC 54276 + Pembrolizumab, GRC 54276 + Atezolizumab
Glenmark Specialty S.A.
Advanced Solid Tumor, Lymphoma
07/27
07/27
NCT01191151: Web Based Orthopaedic Sports Medicine Registry

Terminated
N/A
12500
Europe, Canada, US, RoW
Arthrex, Inc.
Degenerative and Traumatic Pathology of the Knee, Degenerative and Traumatic Pathology of the Shoulder and Elbow, Degenerative and Traumatic Pathology of the Foot and Ankle, Degenerative and Traumatic Pathology of the Hand and Wrist, Degenerative and Traumatic Pathology of the Hip
07/23
07/23
ECLIPSE, NCT03108456: Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The Trial

Active, not recruiting
N/A
2005
US
Orbital Atherectomy, Balloon
Abbott Medical Devices, Cardiovascular Research Foundation, New York
Coronary Artery Disease, Ischemic Heart Disease, Non ST Segment Elevation Myocardial Infarction
06/24
06/25
Ryan, James
START, NCT03021928: Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation

Active, not recruiting
3
200
US
Time-To-Treatment Randomization
University of Texas at Austin, Lone Star Stroke Research Consortium, Texas Department of State Health Services
Stroke
08/23
12/23
NCT05114018: Effect of Pasteurized Akkermansia Muciniphila on Insulin Resistance in Otherwise Healthy Subjects With Dysglycaemia

Completed
N/A
144
Europe
Pasteurized A. muciniphila, placebo
A-Mansia Biotech S.A.
Metabolic Syndrome, Pre-diabetes, Overweight and Obesity
07/23
08/23
Perez, Clauida
START, NCT03021928: Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation

Active, not recruiting
3
200
US
Time-To-Treatment Randomization
University of Texas at Austin, Lone Star Stroke Research Consortium, Texas Department of State Health Services
Stroke
08/23
12/23
Lahoti, Ankush
NCT06055920: The PEERLESS II Study

Recruiting
N/A
1200
Europe, Canada, US
FlowTriever System, Anticoagulation Agents
Inari Medical
Pulmonary Embolism
07/26
07/26
Hollingsworth, John
NCT06055920: The PEERLESS II Study

Recruiting
N/A
1200
Europe, Canada, US
FlowTriever System, Anticoagulation Agents
Inari Medical
Pulmonary Embolism
07/26
07/26

Download Options